In the face of growing health threats and increasingly complex global health challenges, the World Health Organization’s Pandemic Agreement stands as a symbol of hope, signaling the urgent need for global cooperation during health shocks and crises. The recent global health emergencies have underscored the fragility of health systems worldwide, revealing deep inequalities and highlighting the critical importance of building resilient, inclusive, and equitable health infrastructures.
The WHO Pandemic Agreement provides a transformative framework for countries to collectively address these challenges through collaboration, capacity-building, and the equitable distribution of health resources. The health systems lens is central to understanding the full implications of the WHO Pandemic Agreement. As health systems stakeholders, we need to understand what the agreement means for global cooperation in terms of pandemic prevention, preparedness, response, and recovery, emphasizing the vital role of health systems in ensuring that all people, especially those in vulnerable situations, have access to the essential health services they need.
A New Era of Global Health Cooperation
The WHO Pandemic Agreement was adopted by member states of the World Health Organization in a plenary session of the World Health Assembly. This decision was taken by consensus, meaning all member states agreed to it. The 78th World Health Assembly, the WHO’s peak decision-making body, formally adopted the agreement, marking a defining moment in global health governance.
The agreement recognizes that health crises do not respect borders and that only through international collaboration can we build robust systems to withstand pandemics and other public health emergencies. The Agreement underscores the essential role of states, but also highlights that no country can address such complex challenges alone. Thus, it sets the stage for a more coordinated and integrated global approach to health security.
At its core, the WHO Pandemic Agreement seeks to establish the foundations for a future where nations work together to prevent, detect, and respond to pandemics. Recognizing the vast differences in the capacities and resources of different countries, the Agreement stresses that global cooperation must be rooted in supporting the development of health systems in developing nations and those facing the greatest vulnerability, particularly small island developing states and least developed countries (LDCs). This framework fosters an environment where international partnerships can thrive, pooling resources, knowledge, and technologies to ensure that health crises are managed effectively and equitably.
Pandemic Prevention Through “One Health”
A critical element of the WHO Pandemic Agreement is its endorsement of a One Health approach, which recognizes the interconnectedness of human health, the health of domesticated and wild animals, and the environment. Most emerging diseases are zoonotic—caused by pathogens that spill over from animals to humans. The Agreement, therefore, requires countries to develop national pandemic prevention and surveillance plans, including measures to identify and mitigate the drivers of disease at the human-animal-environment interface, prevent spillover, and implement robust surveillance and risk assessment of pathogens.
Countries are encouraged to consider factors that increase pandemic risks, such as deforestation, land use, and climate change, in their national policies. In addition, the Agreement calls for the establishment of joint training for the workforce at the human-animal-environment interface. These obligations are designed to minimize the risks of pandemics by preventing them at their source. This proactive approach is not only essential for reducing the occurrence of zoonotic diseases but also critical for ensuring that health systems are not overwhelmed when such events occur.
By codifying the One Health approach, the WHO Pandemic Agreement helps set the stage for a holistic, integrated model of health security. One that considers the environment, animal health, and human health as intrinsically linked, encouraging coordinated efforts across sectors. This model, in turn, strengthens the foundation of pandemic preparedness, especially in vulnerable regions where risks are higher due to close human-animal interactions and environmental degradation.
Strengthening Health Systems for Pandemic Resilience
One of the central tenets of the WHO Pandemic Agreement is the imperative to strengthen health systems, particularly primary health care, to build resilience against future pandemics. A resilient health system is one that can not only respond to an outbreak but also prevent its spread, manage its impact, and recover swiftly. The COVID-19 pandemic demonstrated how even the most well-developed health systems could be overwhelmed by a rapidly spreading disease. It exposed weaknesses in governance, infrastructure, human resources, and financial systems.
The WHO Pandemic Agreement emphasizes the need for each country to develop and maintain a health system that is capable of responding to health emergencies. This includes strengthening primary health care (PHC), the backbone of any effective health system. PHC has proven to be the most efficient and cost-effective way to ensure health services are available to all, especially in times of crisis.
The Agreement advocates for comprehensive national pandemic preparedness plans that include measures to improve access to quality clinical care, ensure the availability of vaccines and therapeutics, and strengthen health system governance.
Moreover, the WHO Pandemic Agreement underscores the necessity of building a global health workforce that is not only skilled but also adequately protected and supported during crises. The pandemic highlighted the extraordinary contribution of healthcare workers, and yet, many countries were unable to retain, protect, or sufficiently equip their workforce during the emergency. It is essential that the global community supports the creation of an emergency health workforce that is adaptable, diverse, and capable of being mobilized swiftly during pandemics.
Addressing Equity in Health Systems
The COVID-19 pandemic exposed the stark inequalities in health access, with many developing countries and marginalized communities left behind in the race to secure vaccines, treatments, and protective equipment. The WHO Pandemic Agreement takes bold steps toward addressing these inequities by emphasizing the need for equity in pandemic prevention, preparedness, and response. The Agreement calls for the fair and equitable distribution of health products, recognizing that health systems in less developed countries often lack the infrastructure, resources, and capacity to respond to emergencies without substantial international support.
A critical aspect of the Agreement is the creation of a more equitable global supply chain for pandemic-related health products. The establishment of a Global Supply Chain and Logistics Network (GSCL Network) will ensure that vaccines, therapeutics, diagnostics, and other pandemic-related health products are made available to countries in need, particularly developing nations. This commitment to equitable access is fundamental for achieving global health security, as no country can afford to be left behind during a health emergency.
In addition, the Agreement promotes the strengthening of local manufacturing capabilities, particularly in developing countries, to reduce dependence on external supply chains. Local production not only enhances access to essential health products but also helps build the long-term sustainability of health systems. This is a pivotal move towards reducing global health inequalities and ensuring that every country, regardless of its economic status, can respond effectively to health emergencies.
Data Sharing: Ensuring Global Cooperation and Rapid Response
A key component of the WHO Pandemic Agreement is its focus on data sharing, which is essential for coordinating global responses during health crises. Timely and transparent data exchange allows governments and organizations to act swiftly and effectively, ensuring that resources are allocated appropriately.
The Agreement introduces the Pathogen Access and Benefit-Sharing System, which ensures the equitable sharing of pathogen materials and genetic sequence information. This system accelerates the development of vaccines, therapeutics, and diagnostics, particularly in low-resource settings.
Transparency in the procurement of health products is also emphasized, encouraging countries to share data to ensure fair distribution of vaccines, diagnostics, and treatments during pandemics. Additionally, the Agreement strengthens global surveillance by promoting data sharing on emerging diseases and risks, allowing for early detection and rapid response.
In essence, data sharing is central to the WHO Pandemic Agreement, enabling more coordinated and equitable pandemic responses globally. It ensures that no country is left behind in addressing future health crises.
Technology Transfer and Innovation in Health Systems
The WHO Pandemic Agreement also highlights the need for technology transfer and innovation to be central to pandemic preparedness. The Agreement recognizes that a strong, diversified production base for health products, particularly in developing countries, is essential for mitigating the risk of global supply shortages during pandemics. Through technology transfer programs, developing countries can build their own capacity to produce vaccines, diagnostics, and therapeutics, thus reducing their dependence on high-income countries and multinational corporations.
One of the key elements of the Agreement is the promotion of public-private partnerships (PPPs) to support research and development for pandemic-related health products. PPPs can accelerate innovation, enhance access to cutting-edge technologies, and support the rapid scale-up of production during pandemics. The collaboration between governments, international organizations, research institutions, and private enterprises can facilitate the timely development of effective treatments and vaccines, ensuring that these are accessible to all, including the most vulnerable populations.
The WHO Pandemic Agreement provides an essential framework for accelerating the adoption of digital health solutions, which will play a vital role in monitoring health systems, coordinating responses, and ensuring continuity of care during emergencies.
The Importance of Multisectoral Collaboration
Pandemics are complex, multifaceted crises that affect not only the health sector but also the social, economic, and political fabric of societies. Therefore, addressing them requires a multisectoral approach that involves collaboration across various sectors, including education, agriculture, transport, and environmental protection. The WHO Pandemic Agreement promotes this whole-of-government and whole-of-society approach, which encourages all sectors to contribute to pandemic prevention and response.
The Agreement recognizes that pandemics often exacerbate existing vulnerabilities, particularly in low-income and marginalized communities. It calls for governments to adopt comprehensive, multisectoral pandemic preparedness plans that address not only health needs but also the socioeconomic impacts of pandemics. This approach ensures that countries are not only able to respond to immediate health needs but also to the long-term consequences of pandemics, including economic downturns, educational disruptions, and social inequalities. In practice, multisectoral collaboration means that governments, international organizations, civil society, the private sector, and communities must work together to implement effective pandemic prevention strategies.
Success Potential of the Agreement: What Extra Mile Must Countries Go?
While the WHO Pandemic Agreement offers an ambitious and transformative approach to global health security, its success will ultimately depend on the commitment and actions of all parties involved. For the Agreement to be successful, countries must go beyond just signing a document; they must fully implement the measures outlined, including strengthening their health systems, ensuring equitable access to health products, and fostering innovation in pandemic preparedness.
The challenge lies in translating the theoretical framework into tangible action. Developing countries, in particular, face significant challenges in mobilizing the necessary resources, technologies, and expertise to implement the provisions of the Agreement. The global community must stand united in supporting these countries, ensuring that they are not left behind in the race to build resilient health systems.
Moreover, while the Agreement calls for equitable distribution of health products, countries must be proactive in addressing systemic barriers to access, such as intellectual property concerns and trade restrictions. Only through coordinated efforts and transparent, inclusive mechanisms can we ensure that health products are accessible to all, regardless of their country’s economic status.
The Road Ahead: A Call for Action
As we move forward in the post-pandemic world, the WHO Pandemic Agreement offers a comprehensive and actionable framework for transforming global health cooperation. To truly realize the promise of this Agreement, all Parties must commit to strengthening their health systems, ensuring equitable access to health products, and fostering innovation in pandemic preparedness.
The COVID-19 pandemic has shown us that the world cannot afford to wait until a crisis strikes to act. Now is the time to invest in building health systems that are robust, resilient, and ready to respond to future health emergencies. The WHO Pandemic Agreement provides the blueprint for achieving this goal, and it is our collective responsibility to ensure its implementation. The WHO Pandemic Agreement is a call to action. It is an opportunity to build a more equitable, resilient, and sustainable global health system for future generations. It is time for us all to act together.
The author Dr. N. Krishna Reddy is CEO, ACCESS Health International. The views expressed in this article are personal.
Image credit: WHO